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Decision-making depends on the ability to extract predictive information from the environment to guide future actions. Outcome-
specific Pavlovian-instrumental transfer (PIT) provides an animal model of this process in which a stimulus predicting a particular
outcome biases choice toward actions earning that outcome. Recent evidence suggests that cellular adaptations of -opioid receptors
(DORs) on cholinergic interneurons (CINs) in the nucleus accumbens shell (NAc-S) are necessary for PIT. Here we found that modulation of
DORsinCINscritically influencesD1-receptor(D1R)-expressingprojectionneuronsintheNAc-StopromotePIT.First,weassessedPIT-induced
changes in signalingprocesses indopamineD1- andD2-receptor-expressingneuronsusingdrd2-eGFPmice, and found that PIT-related signal-
ing was restricted to non-D2R-eGFP-expressing neurons, suggestingmajor involvement of D1R-neurons. Next we confirmed the role of D1Rs
pharmacologically: theD1RantagonistSCH-23390,butnot theD2Rantagonist raclopride, infused into theNAc-SabolishedPIT inrats, aneffect
that depended on DOR activity. Moreover, asymmetrical infusion of SCH-23390 and the DOR antagonist naltrindole into the NAc-S also abol-
ishedPIT.DORagonistswerefoundtosensitizethefiringresponsesofCINsinbrainslicespreparedimmediatelyafterthePITtest.Weconfirmed
the opioid-acetylcholinergic influence over D1R-neurons by selectively blockingmuscarinicM4 receptors in the NAc-S, which tightly regulate
the activity of D1Rs, a treatment that rescued the deficit in PIT induced by naltrindole.We describe amodel of NAc-S function in which DORs
modulate CINs to influence bothD1R-neurons and stimulus-guided choice between goal-directed actions.
Key words: goal-directed action; choice; nucleus accumbens shell; -opioid receptor; dopamine receptor; muscarinic acetylcholine
receptor M4
Introduction
Pavlovian conditioning imbues a stimulus with the ability to in-
fluence future actions; i.e., a stimulus associated with a particular
outcome biases choice toward actions that earn that same out-
come (Colwill and Rescorla, 1988; Dickinson and Balleine, 1994;
Holmes et al., 2010). Considerable evidence suggests that this
outcome-specific Pavlovian-instrumental transfer effect (PIT)
requires activity in the nucleus accumbens shell (NAc-S); lesion
(Corbit et al., 2001) or inactivation (Corbit and Balleine, 2011) of
the NAc-S removes the influence of predictive stimuli on choice.
Interestingly, these manipulations appeared not to affect either
the stimulus–outcome or action–outcome relationships that in-
teract in the expression of specific PIT, suggesting that the NAc-S
extracts and integrates information from both Pavlovian and in-
strumental training to control the influence of outcome-related
stimuli on choice between actions.
Recent evidence suggests that -opioid receptors (DORs) in
the NAc-S play an essential role in specific PIT (Laurent et al.,
2012; Bertran-Gonzalez et al., 2013). We first observed that spe-
cific PIT was selectively impaired by genetic deletion of DORs,
as well as by systemic or local blockade of DORs in the NAc-S
(Laurent et al., 2012). Subsequently, we found that successful
outcome-specific transfer was associated with an increase of
DOR expression in the somatic membrane of cholinergic in-
terneurons (CINs) in the NAc-S. This plastic cellular response
occurred during Pavlovian conditioning and required the pres-
ence of specific stimulus–outcome relationships (Bertran-Gonzalez
et al., 2013). Together, these findings suggest that Pavlovian con-
ditioning produced a persistent translocation of DORs to the
somatic membrane of NAc-S CINs, and that this translocation is
later necessary to promote the influence of outcome-related
stimuli on choice between actions. Nevertheless, the effects of
these local changes in cholinergic activity on the overall function-
ing of the NAc-S remain unknown.
It is well established that, like the rest of the striatum, the
NAc-S is composed almost exclusively of medium-sized spiny
neurons (MSNs), which constitute the only output neurons of
this structure (Gerfen and Surmeier, 2011). These MSNs, which
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are intermingled in the tissue, can be separated into two distinct
populations based on the dopamine receptor type they express, a
distinction that, at least in dorsal areas, reflects the divergent
pathways projecting from the striatum (Bertran-Gonzalez et al.,
2010). Although this segregation appears less pronounced in ven-
tral striatal regions (Smith et al., 2013), striatonigral MSNs gener-
ally express dopamine D1 receptors (D1Rs), whereas striatopallidal
MSNs are enriched in dopamine D2 receptors (D2Rs). Given this
distinction, the present experiments first aimed to determine
which projection population in the NAc-S was primarily in-
volved in the expression of specific PIT and, second, to investigate
how DOR-mediated changes in cholinergic activity modulate
MSN function to promote the influence of Pavlovian predictors
on choice between actions.
Materials andMethods
Subjects
Swiss-Webster drd2-eGFP mice carrying a bacterial artificial chromo-
some (BAC) expressing eGFP under drd2 regulatory sequences were ob-
tained from the GENSAT (Gene Expression Nervous System Atlas)
program at Rockefeller University (New York, NY). These mice were
crossed with C57BL/6 wild-type mice, and stable heterozygous mice from
theF1 generationwere used in this study (13mice in total,male, and aged
8–10 weeks). They were housed in plastic boxes (two to five mice per
box) located in a climate-controlled colony room and were maintained
on a 12 h light/dark cycle. A total of 109 experimentally naive Long–
Evans rats (aged 7–12 weeks) were obtained from Monash University
Animal Research Platform. They were housed in plastic boxes (two or
three rats per box) located in a separate colony room. Five days before the
behavioral procedures, all animals were handled daily and were put on a
food deprivation schedule to maintain them at85% of their ad libitum
feeding weight. The Animal Ethics Committee at the University of Syd-
ney approved all experimental procedures.
Apparatus
Training and testing took place in 32MED Associates operant chambers
(16 formice and 16 for rats) enclosed in sound- and light-resistant shells.
Each chamber was equipped with a pump fitted with a syringe that could
deliver 0.1 ml of a 20% sucrose solution into a recessed magazine in the
chamber. Each chamber was also equipped with two pellet dispensers
that could individually deliver either grain food pellets (20 mg for mice
and 45 mg for rats; BioServe Biotechnologies) or chocolate food pellets
(20 mg for mice) when activated. The chambers contained two retract-
able levers that could be inserted to the left and right side of themagazine.
An infrared photobeam crossed the magazine opening, allowing for the
detection of head entries. A 3W, 24 V house light provided illumination
of the operant chamber, and each chamber contained a Sonalert that,
when activated, delivered a 3 kHz pure tone, a 28 V DCmechanical relay
that was used to deliver a 2 Hz clicker stimulus, and a white noise gener-
ator (80 dB). A set of four microcomputers running MED Associates
proprietary software (Med-PC) controlled all experimental events and
recorded magazine entries and lever presses.
Drugs
R-()-SCH-23390 hydrochloride (SCH; Sigma-Aldrich), a selective
D1Rantagonist,S-()-raclopride ()-tartrate salt (RAC; Sigma-Aldrich), a
selectiveD2R antagonist, andMuscarinic Toxin 3 (MT3; Peptides Interna-
tional), a highly selective muscarinic M4 receptor (M4R) antagonist,
were all dissolved in 0.9% (w/v) nonpyrogenic saline. Two concentra-
tions (2.5 g/l and 1 g/l) of the D1 and D2 dopamine antagonists
were used (Baldo et al., 2002; Bossert et al., 2007; Faure et al., 2008),
whereas one concentration (4 g/l) of MT3 was used (Diehl et al.,
2007). For intracranial infusions, theDOR antagonist naltrindole hydro-
chloride (NAL; Tocris Bioscience) was dissolved in 0.9% (w/v) saline
containing 5%DMSO toobtain a final concentration of 5g/l (Laurent
et al., 2012). The same concentration (Perrine et al., 2006) was used for
systemic administration (intraperitoneal) of NAL at a volume of 10
ml/kg which, in that case, was dissolved in distilled water. Either 0.9%
(w/v) saline (SCH, RAC, and MT3), 0.9% (w/v) saline containing 5%
DMSO (for intracranial injection of NAL), or distilled water (for sys-
temic injection ofNAL)was used as vehicle (VEH) in each case to control
for any effect of the injection procedure per se. Working drug concen-
trations for electrophysiology were as follows: picrotoxin (100 M;
Sigma-Aldrich), CNQX disodium and DL-AP5 (10 and 100 M, respec-
tively; Ascent Scientific), deltorphin II (300 nM; Tocris Bioscience).
During cell-attached and whole-cell recording experiments, stock so-
lutions of all drugs were diluted to working concentrations in the
extracellular solution immediately before use and applied by contin-
uous superfusion.
Surgery and microinjections
At the time of surgery, rats weighted between 290 and 360 g. Continuous
flow of mixed isoflurane and oxygen gas solution was used to anesthetize
rats that were then placed in a stereotaxic frame (Kopf Instruments) with
the incisor bar set at 3.3 mm. The scalp was retracted to expose the
skull, and 26 gauge guide cannulae (Plastics One) were bilaterally im-
planted throughholes drilled in the skull in one of the targeted structures.
Two different sets of coordinates (indicated in millimeters relative to
bregma) were used for the core region of the nucleus accumbens: one for
the left [anteroposterior (AP),1.2;mediolateral (ML),2.1; dorsoven-
tral (DV),6.0] and one for the right (AP,1.2; ML,3.2; DV,6.2;
angled 10° toward the midline in the coronal plane) hemisphere. The
coordinates used for the shell region of the nucleus accumbens were the
following: AP, 1.7; ML, 0.75; DV, 6.4. The guide cannulae were
maintained in position with dental cement, and dummy cannulae were
kept in each guide at all times except during microinjections. Immedi-
ately after the surgical procedure, rats were injected i.p. with a prophy-
lactic (0.4 ml) dose of 300 mg/kg solution of procaine penicillin. Rats
were allowed 3 d to recover from surgery, during which time they were
handled and weighed daily.
SCH-23390, raclopride, naltrindole, MT3, and vehicle were infused
into either the core or the shell region of the nucleus accumbens by
inserting a 33 gauge infusion cannula into the guide. The infusion can-
nulae were connected to a 25 l glass syringe connected to an infusion
pump (KD Scientific, SDR Clinical Technology) and projected 1 mm
ventral to the tip of the guide. A total volume of 0.2 l was delivered
at a rate of 0.1 l/min. The infusion cannula remained in place for a
further 1 min after the infusion and then removed. On the day before
the first infusion, the dummy cannula was removed and the infusion
pump was turned on for 2 min to familiarize the rats with the proce-
dure and thereby minimize any stress produced by this procedure
when infusions occurred.
Behavioral procedures
Contingent Pavlovian training. All animals received eight daily sessions
of Pavlovian training during which the levers were retracted. Each
session was of 60 min duration and consisted in presenting two con-
ditioned stimuli (noise and clicker for mice, tone and clicker for rats),
each paired with one of the two food outcomes used (grain or choc-
olate pellets for mice, grain pellets or sucrose solution for rats). Each
stimulus lasted 2 min in duration and was presented four times in a
pseudorandom order with a variable intertrial interval of 5 min. The
stimulus–outcome relationships were fully counterbalanced. The su-
crose or pellets were delivered on a random-time 30 s schedule through-
out the appropriate stimulus.
Noncontingent Pavlovian training. This training was identical to con-
tingent training except the conditioned stimuli and the delivery of the
outcomes were uncorrelated and dispersed across the entire session.
Thus, the stimulus–outcome predictive relationships were weakened in
this group, as the outcomes could be obtained in the absence or presence
of either stimulus. The number of O1 and O2 delivered in one noncon-
tingent training session was identical to the number of O1 and O2 given
in one contingent training session.
Instrumental training. Following Pavlovian training, all animals re-
ceived 8 d of instrumental training during which two responses (left and
right lever presses) were trained with the two different food outcomes in
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separate daily sessions. The order of the sessions was counterbalanced, as
were the response–outcome relationships that were also counterbal-
anced with the stimulus–outcome relationships established during Pav-
lovian training. Each session ended when 20 outcomes were earned or
when 30 min had elapsed. For the first 2 d, lever pressing was continu-
ously reinforced (i.e., each response was reinforced). Then, the probabil-
ity of the outcome given a response was gradually shifted over days using
increasing random ratio schedules: a RR5 schedule (p 0.2) was used on
days 3–5 and a RR10 (p 0.1) was used on days 6–8. For experiments
involving cannulations, ratswere then given ad libitum access to food and
water for 5 consecutive days before undergoing surgery. Following recov-
ery from surgery, rats were returned to the food deprivation schedule
previously used and received 2 additional days of instrumental training
on a RR10 schedule.
Pavlovian-instrumental transfer. After the final day of RR10 training,
animals were given a Pavlovian-instrumental transfer test. Both levers
were inserted into the box, but no outcomes were delivered. Responding
was extinguished on both levers for 8 min to reduce baseline perfor-
mance. Each stimuluswas then presented four times over the next 40min
in the following order: clicker-noise-noise-clicker-noise-clicker-clicker-
noise. For rats, the noise was replaced by a tone. Stimulus presentations
lasted 2 min and were separated by a 3 min fixed interval. In pharmaco-
logical experiments, all microinjections were given 15 min before test
except for the systemic administration of naltrindole that occurred 30
min before. The order of these microinjections was fully counterbal-
anced. That is, rats that received vehicle infusion on Test 1 were infused
with drug on Test 2, whereas rats infused with drug on Test 1 received
vehicle on Test 2. In some experiments (i.e., DOR/D1R blockade and
MT3 blockade), full counterbalancing was not possible due to the high
number of different drug treatments. However, the order of microinjec-
tions used ensured maximal counterbalancing. Finally, “Same” in non-
contingent animals was defined as left lever press rate minus baseline,
whereas “Different” corresponded to right lever press rate minus base-
line. This pseudorandomallocation of performancewas justified because
noncontingent training prevented the establishment of specific relation-
ships between the stimuli and the outcomes.
Tissue preparation to control for cannulae placements
At the end of the experiment, the rats received a lethal dose of sodium
pentobarbital (300 mg/kg; Virbac Pty. Ltd.). The brains were removed,
frozen, and sectioned coronally with a cryostat (LeicaMicrosystemsAus-
tralia) at 40 m through the core or the shell region of the nucleus
accumbens. Every third section was collected on a slide, and the sections
were stained with cresyl violet. The location of cannulae tips was deter-
mined under amicroscope by a trained observer whowas unaware of the
subjects’ group designations using boundaries defined in the atlas of
Paxinos and Watson (2006). Subjects with inaccurate cannulae place-
ments or with extensive damage at the infusion site were excluded from
the statistical analysis.
Transcardial fixation andbrain sectioning for
immunofluorescence
After the test, mice were rapidly anesthetized with sodium pentobarbital
(500 mg/kg, i.p. in mice) and transcardially perfused with cold 4% para-
formaldehyde in 0.1 M sodium phosphate buffer, pH 7.5. Brains were
postfixed in the same solution at 4°C overnight. Coronal 30-m-thick
sections (1.3 from bregma in mice) were cut with a vibratome (Leica
Microsystems VT1000) and stored at 20°C in a solution containing
30% ethylene glycol, 30% glycerol, and 0.1 M sodium phosphate buffer,
until they were processed for immunofluorescence.
Immunofluorescence
Individualized free-floating sections were rinsed in Tris-buffered saline
with NaF (TBS-NaF; 0.25 M Tris, 0.5 M NaCl, and 0.1 mM NaF, pH 7.5),
incubated for 5 min in TBS-NaF containing 3% H2O2 and 10% metha-
nol, and then rinsed 10 min three times in TBS-NaF. After 20 min incu-
bation in 0.2% Triton X-100 in TBS-NaF, sections were rinsed three
times in TBS-NaF again. DARPP-32 and the double-phosphorylated
form of ERK1/2 (phospho-Thr202/Tyr 204-ERK1/2) were simultaneously
detected in drd2-eGFPmice through incubation with combined purified
mouse anti-DARPP-32 (1:300, catalog #611520; BD Biosciences) and
polyclonal rabbit anti-phospho-Thr202/Tyr 204 ERK1/2 (1:300, catalog
#9101; Cell Signaling Technology) primary antibodies diluted in TBS-
NaF (4°C, overnight). All sections were then rinsed 10 min in TBS-NaF
three times and incubated 60 min with combined donkey anti-mouse
Alexa Fluor 647-coupled and donkey anti-rabbit CY3-coupled antibod-
ies diluted 1:400 in TBS. Sections were rinsed four times for 10 min in
TBS before mounting in Vectashield fluorescence medium (Vector
Laboratories).
Fluorescence analysis
In drd2-eGFP mice, 635.2 m2 confocal images were obtained in the
ventromedial extension of the nucleus accumbens shell (approximate
coordinates AP, 1.3; ML, 0.8; DV, 5) using sequential laser scan-
ning confocalmicroscopy (Olympus FV1000). Samples contained simul-
taneous eGFP, phospho-ERK1/2, and DARPP-32 staining, which were
scanned sequentially at 2519 pixels/m resolution (Ch01, Ch02, and
Ch03, respectively). Before quantification, all image files were randomly
renumbered using aMS Excel plug-in (Bio-excel2007 by Romain Bouju,
France). Cell counts were performed in Open Source ImageJ software
(MacBiophotonics upgrade v. 1.43u, Wayne Rasband, National Insti-
tutes of Health, Bethesda,MD) as follows. (1) Total amount of phospho-
ERK1/2-immunoreactive neurons was marked and quantified in Ch02.
(2) Phospho-ERK1/2 marks were superimposed to Ch01 (eGFP), and
coincident phospho-ERK1/2- and eGFP-immunoreactive neurons
were requantified (D2). (3) Phospho-ERK1/2 marks were superim-
posed on Ch03 (DARPP-32), and phosho-ERK1/2-immunoreactive
neurons that were negative for DARPP-32 were requantified (non-
MSNs). The number of phospho-ERK1/2-immunoreactive cells (p-
ERK1/2 neurons) contained in D1-MSNs (D1) was calculated as (1)
minus (2) minus (3). The small bias produced by cells that were
pERK1/2-positive, eGFP-positive, and DARPP-32-negative (0.42%
in our study) was not considered.
Brain slice preparation
Male Long–Evan rats (12–15 weeks old) that had undergone a prior PIT
test were deeply anaesthetized using isoflurane inhalation (4% in air),
decapitated and their brain removed. Horizontal brain slices (300 m
thick) containing the NAc-S were cut using a vibratome (Leica Micro-
systems VT1200S) in ice-cold oxygenated sucrose cutting solution con-
taining the following (in mM): 241 sucrose, 28 NaHCO3, 11 glucose, 1.4
NaH2PO4, 3.3 KCl, 0.2 CaCl2, 7MgCl2. Slices were hemisected atmidline
and maintained at 33°C in a submerged chamber containing physiolog-
ical saline with the following composition (inmM): 126NaCl, 2.5KCl, 1.4
NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 11 glucose, and 25 NaHCO3, and equili-
brated with 95%O2 and 5%CO2.
Electrophysiological recording and post hoc histological
analysis
After equilibrating for 1 h, slices were then transferred to a recording
chamber and visualized under an upright microscope (Olympus BX50WI)
using differential interference contrast (DIC) Dodt tube optics, and super-
fused continuously (1.5 ml min1) with oxygenated physiological saline
at 33°C. Cell-attached andwhole-cell patch-clamp recordings weremade
using electrodes (2–5M) containing internal solution consisting of the
following (in mM): 115 K gluconate, 20 NaCl, 1 MgCl2, 10 HEPES, 11
EGTA, 5Mg-ATP, and 0.33Na-GTP, pH7.3, osmolarity 285–290mOsm
l1. Biocytin (0.1%; Sigma-Aldrich) was routinely added to the internal
solution for marking the sampled neurons during whole-cell recording.
Data acquisition was performed with aMulticlamp 700B amplifier (Mo-
lecular Devices), connected to a Macintosh computer and interface
ITC-18 (Instrutech). In cell-attached mode, action potentials were sam-
pled at 5 kHz (low pass filter 2 kHz) and whole-cell currents were also
sampled at 5 kHz (low pass filter 2 kHz; AxographX,MolecularDevices).
Whole-cell recordings were established immediately following data col-
lection in cell-attached mode. Data from cell-attached and whole-cell
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recordings were only included in analyses if (1) the neurons appeared
healthy under DIC on the monitor screen, (2) cholinergic interneurons
were spontaneously active during cell-attached recording, (3) action po-
tential amplitudes were at least 60 mV above threshold after establishing
whole-cell recordingmode, and (4) neurons demonstrated physiological
characteristics of cholinergic interneurons such as the presence of
hyperpolarization-activated cation current Ih but no plateau low-threshold
spiking (Kawaguchi et al., 1995), to ensure that only highly viable neu-
rons were included.
Immediately after physiological recording, brain slices containing
biocytin-filled neurons were fixed overnight in 4% paraformaldehyde/
0.16 M phosphate buffer (PB) solution and then placed in 0.3% Triton
X-100/PB for 3 d to permeabilize cells. Slices were then placed in 10%
horse serum/PB for 1 h before being incubated in primary goat anti-
choline acetyltransferase (anti-ChAT, 1:500; Millipore) for 2 d at 4°C to
aid identification of CINs. The slices were rinsed in PB and then in a
one-step incubation containing both Alexa Fluor 488-conjugated don-
key anti-goat secondary antibody (1:500; Life Technologies) and Alexa
Fluor 647-conjugated Streptavidin (1:1000; Life Technologies) for 2 h.
Stained slices were rinsed, mounted onto glass slides, dried, and cover-
slipped with Vectashield mounting medium (Vector Laboratories). Im-
ages were obtained using sequential laser scanning confocal microscopy
(Fluoview FV1000, BX61WI microscope, Olympus).
Statistical methods
Statistical analyses were conducted using within-subjects or mixed-
model ANOVA depending on the experimental design (unless stated
otherwise). For all analyses, significance was assessed against a type I
error rate of 0.05. ANOVAswere followed by simplemain effects analyses
to establish the source of any significant interactions.
Results
Specific PIT increases ERK1/2 phosphorylation in D1R-
expressingMSNs in the NAc-S
Based on the functional dichotomy of D1 and D2 receptors in
striatal tissue (Gerfen and Surmeier, 2011), we first sought to
examine which neuronal population was primarily engaged in
the NAc-S during the expression of PIT. For this, we took
advantage of drd2-eGFPmice, which endogenously label D2R-
expressing neurons and have been found to be extremely useful
for functional histology studies (Valjent et al., 2009), as accurate
recognition of D2R-expressing neurons is possible without signal
amplification due to the intensity of the fluorescence signal
(Matamales et al., 2009). We combined drd2-eGFP fluorescence
withDARPP-32 immunostaining, a reliablemarker of bothD1R-
and D2R-expressing MSNs, to accurately distinguish between
D2R-MSNs (i.e., those expressing DARPP-32 and eGFP fluores-
cence) and D1R-MSNs (i.e., those expressing DARPP-32 but not
eGFP fluorescence; Matamales et al., 2009). In the present exper-
iment, food-deprived drd2-eGFP mice were subjected to a
specific PIT protocol involving three stages (Fig. 1A). In the Pav-
lovian stage, all mice were trained to associate two auditory stim-
uli (S1 and S2) with the delivery of two distinct food outcomes
(O1 and O2). In the instrumental stage, mice learned that one
action (A1; i.e., pressing one lever) delivered one of the food
outcomes (O1), whereas another action (A2; i.e., pressing an-
other lever) delivered the other outcome (O2). Mice were then
separated into two groups. One group (Group PIT; n  7) re-
ceived a PIT test during which performance on the levers was
A
B 
D
C
E
F
Figure 1. Specific PIT exposure triggers strong ERK1/2 signaling responses selectively in D1R-MSNs of the NAc-S. A, All mice received Pavlovian and instrumental training. A single PIT test was
given to one group of mice (Group PIT, black) whereas it was omitted for the other group (Group No PIT, red). B–D, Pavlovian training (B) produced a gradual increase in magazine entries during
presentationof the conditioned stimulus. The lever press rate gradually increased across instrumental training (C). GroupPIT exhibited ahigher lever press ratewhen the stimulus predicted the same
outcomeas the response (Same) thanwhen the stimulus predicted adifferent outcome (Different) orwhen therewasno stimulus (Baseline)D, Immediately after the test, allmicewere perfused and
brain samples processed for optimal phosphorylation signal (see Materials and Methods). E, F, Three-staining immunofluorescence (F ) was conducted to label eGFP (identifying D2R-MSNs),
phospho-ERK1/2 (p-ERK1/2; identifying activated neurons) and DARPP-32 (D-32; identifying all MSNs) in the NAc-S of trained drd2-eGFPmice exposed (Group PIT) or not exposed (Group No PIT) to
the PIT test. Almost all p-ERK1/2-activatedneuronswere identified asMSNs (D-32 immunoreactive, data not shown). For quantification (E), neuronswere classified as eGFPorNon-eGFP, depending
on the presence or absence of D2R-eGFP. PIT exposure induced large numbers of phospho-ERK1/2-immunoreactive neurons in the NAc-S, which were almost entirely excluded from D2R-eGFP
fluorescence. Error bars denote1 SEM.
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assessed both in the absence and the presence of S1 and S2. The
mice were rapidly anesthetized and transcardially perfused im-
mediately after this stage. The other group of mice (Group No
PIT; n  6) received the same procedure except they did not
receive the PIT test.
Pavlovian training (Fig. 1B) occurred smoothly since the lev-
els of magazine entry were higher in the presence of the stimuli
(i.e., S period) than in their absence (i.e., Pre-S period; F(1,84)
42.263; p  0.001), and these levels increased across training
(F(7,207) 17.0; p 0.001). There was no difference between the
two groups of mice, and the gradual increase in responding did
not depend on the group’s allocation (F values 2.3). During
instrumental training (Fig. 1C), all mice acquired the lever press
responding that increased as the ratio parameters to earn the
outcomes increased across days (F(7,77) 5.3; p 0.001). Again,
mice in Groups PIT and no PIT did not differ (F values 1.2).
Figure 1D shows the performance of Group PIT as the mean
number of lever presses per minute when the stimuli predicted
the same outcome as the action (Same), when the stimuli pre-
dicted a different outcome from the action (Different), or when
there was no stimulus (Baseline). There was clear evidence of
outcome-specific PIT, as a stimulus trained to predict a par-
ticular outcome elevated responding on the action earning that
same outcome (Same vs Different: F(1,13) 18.0; p 0.01; Same
vs Baseline: F(1,13) 14.4; p 0.01).
Next, to study which neuronal population was principally en-
gaged during PIT, we used immunodetection of the doubly phos-
phorylated form of the MAPK-ERK1/2, a method extensively
used to visualize activated neurons in the striatum (Valjent et al.,
2000; Bertran-Gonzalez et al., 2008). We used confocal micros-
copy on drd2-eGFP mice combined with DARPP-32 immuno-
staining to assess whichMSN population in the NAc-S expressed
ERK1/2 phosphorylation following the test. The results, which
are presented in Figure 1, E and F, revealed distinct patterns of
activation depending on both the subpopulation concerned and
the behavioral protocol administered (F(1,25)  6.9; p  0.05).
There was a clear increase in the number of neurons expressing
phospho-ERK1/2 immunoreactivity when trained animals were
exposed to PIT compared with those trained but not given the
specific PIT test (F(1,11)  5.7; p  0.05). Strikingly, the vast
majority of phospho-ERK1/2-immunoreactive neurons in Group
PIT, although expressing DARPP-32, did not express eGFP
(F(1,11)  7.2; p  0.05; Fig. 1F). Animals in Group No PIT
showed low ERK1/2 activation levels in all DARPP-32 neurons
whether they expressed eGFP or not (F  1). In our quantifica-
tion (Fig. 1E), we classified p-ERK1/2-immunoreactive neurons
as eGFP (i.e., D2R-expressing MSNs) and non-eGFP (i.e., D2R-
negative MSNs), according to their fluorescence profile. Our re-
sults clearly showed that exposure to the PIT test was associated
with an increase of p-ERK1/2 immunoreactivity in non-eGFP,
DARRP-32-positive neurons, i.e., putative D1R MSNs in the
NAc-S. These results suggest that specific PIT depends on activity
in D1R-expressing projection neurons of the NAc-S.
D1R activity in the NAc-S is critical for specific PIT
Next, we used a pharmacological approach in rats to confirm the
role played by D1R- and D2R-expressing MSNs in the NAc-S
during specific PIT. Food-deprived rats were subjected to a spe-
cific PIT protocol similar to the one described above except for
two differences (Fig. 2). The first was that rats were bilaterally
implanted with cannulae into the NAc-S (Fig. 2E, left) during the
course of instrumental training. The second difference is that
there were two rounds of PIT tests (Fig. 2A). One round of tests
(PIT 1) evaluated the effects of relatively high doses of D1R and
D2R antagonists (High dose), whereas a second round (PIT 2;
after retraining) assessed the effects of lower doses of the same
drugs (Low dose).
All rats learned the predictive relationships across Pavlovian
training (data not shown) as indicated by higher levels of maga-
zine entries in the presence of the stimuli than in their absence
(F(1,98)  91.3; p  0.001). Further, these levels gradually in-
creased across days (F(7,239) 7.6; p 0.001). During instrumen-
tal training (data not shown), all animals acquired the lever press
responding that increased as the ratio schedules increased across
days (F(9,149)  96.5; p  0.001). On each testing round (PIT 1
and PIT 2), two tests were given on 2 consecutive days (Fig.
2B,C). On PIT 1, two groups of rats (n  8) performed the
transfer tests after NAc-S infusion of either VEH or the D1R
antagonist SCH (2.5 g/l). The D1R antagonist had a strong
effect on outcome-specific transfer (Fig. 2B). ANOVA conducted
using factors of Drug and of Period (separating Same, Different,
and Baseline) showed a main effect of Drug (F(1,14)  18.1; p 
0.001), Period (F(2,14)  16.4; p  0.001), and a Drug 	 Period
interaction (F(2,47) 10.7; p 0.001). Simple-effects analyses on
the significant interaction revealed significant PIT in vehicle-
treated rats (F(2,14) 17.5; p 0.001) but not in rats infused with
SCH (F 3.5). However, the impairment was not specific to the
presence of the stimuli as SCH-treated animals displayed lower
instrumental performance during Baseline than did control ani-
mals (F(1,14)  15.4; p  0.01). This implies that SCH-23390
induced a general decrease in instrumental responding rather
than a specific removal of outcome-specific PIT. As a conse-
quence, the same animals were given additional instrumental
training before being retested under a lower dose of the D1R
antagonist (PIT 2; 1g/l). The data presented in the right panel
of Figure 2B clearly shows that SCH-23390 prevented outcome-
specific PIT. ANOVA revealed no main effect of Drug (F  1),
but a main effect of Period (F(2,14)  17.7; p  0.001) and a
Drug 	 Period interaction (F(2,47)  5.6; p  0.05). Rats dis-
played a selective increase in instrumental responding during
stimulus Same when treated with vehicle (F(1,15)  18.8; p 
0.001) but not when given SCH-23390 (F  0.3). Importantly,
these effects only emerged during the stimuli; there was no dif-
ference between groups during test in the Baseline period (F 1).
In another set of rats run in parallel, we also examined in two
rounds of testing the effects of NAc-S infusions of high and low
doses of the D2R antagonist raclopride (2.5 g/l and 1 g/l)
on outcome-specific PIT. The left panel of Figure 2C shows that,
at a high dose, raclopride had very little if any impact on
outcome-specific PIT. The statistical analysis revealed a main
effect of Period (F(2,12) 15.6; p 0.001) but no main effect of
Drug or no Drug 	 Period interaction (Fs1.5). Not surpris-
ingly, the exact same outcomewas observed when a lower dose of
raclopride was used in PIT 2 (Fig. 2C, right). Again, ANOVA
showed a main effect of Period (F(2,12) 11.9; p 0.001) but no
main effect of drug or no drug 	 lever interaction (F values
3.5). Thus, raclopride failed to impair specific PIT regardless of
the dose infused into the NAc-S.
These effects of SCH-23390 were specific to infusions into the
NAc-S. Two groups of rats received the sameprotocol except they
were bilaterally cannulated in the nucleus accumbens core
(NAc-C; Fig. 2E, right). One group (n 9) received the PIT tests
under infusion of either VEH or SCH-23390 (1g/l), while the
other group (n 7) was infused with either VEH or raclopride (1
g/l). Pavlovian and instrumental training occurred without
incident (data not shown). Rats discriminated between the S and
1362 • J. Neurosci., January 22, 2014 • 34(4):1358–1369 Laurent et al. • Opioid–Acetylcholine–Dopamine Interactions in PIT
pre-S periods (F(1,105) 146.3; p 0.001), and this discrimination
grew larger over the course of training (F(7,255) 17.3; p 0.001),
as did the instrumental performance (F(9,159) 129.9; p 0.001).
The data of rats tested under SCH or vehicle are presented in the
left panel of Figure 2D. ANOVA revealed a main effect of Period
(F(2,16)  45.1; p  0.001), but no effect of Drug or a Drug 	
Period interaction (F values 3.5). Thus, the Same stimuli ele-
vated responding on the action when they predicted the same
outcome relative both to baseline (F(1,35) 35.4; p 0.001) and
to the Different stimulus (F(1,35)  24.7; p  0.001). A similar
effect was observed in the test of raclopride (Fig. 2D, right), as the
analysis revealed amain effect of Period (F(2,12) 9.3; p 0.001),
but no effect of Drug or a Drug 	 Period interaction (F values
2.2). Thus, neither D1R nor D2R activation in the NAc-C is
essential for specific PIT.
D1R- and DOR-related processes interact in the NAc-S to
promote specific PIT
Our current and past results point to the involvement of a dopa-
minergic process, through D1Rs expressed in postsynaptic pro-
jection neurons, and an opioidergic process, through DORs
expressed on cholinergic interneurons, in the NAc-S as key fac-
tors promoting the influence of stimuli on choice between ac-
tions (Laurent et al., 2012). In the present experiment, we sought
to assess whether these processes interact in driving the PIT effect
or whether they provide independent sources of control over that
effect. To achieve this, we gave rats asymmetrical infusions of the
D1R and DOR antagonists SCH-23390 and naltrindole into the
NAc-S. Rats were cannulated in the NAc-S (Fig. 3C) and then
subjected to the specific PIT protocol described previously. All
rats received four PIT tests that were conducted under the influ-
ence of distinct pharmacological treatments involving symmetri-
cal or asymmetrical bilateral infusions in the NAc-S (Fig. 3A).
Pavlovian conditioning was successful as rats exhibited more
magazine entries during the stimulus period than during the pre-
stimulus period (F(1,304)  421.7; p  0.001; data not shown).
Further, the levels ofmagazine entries during the stimulus period
increased as training progressed (F(7,319) 11.4; p 0.001; data
not shown). All rats acquired lever press responding that in-
creased over the course of instrumental training (F(1,190) 32.5;
p 0.001; data not shown).
After Pavlovian and instrumental training, we exposed these
rats to the different pharmacological treatments (Fig. 3A) imme-
diately before the outcome-specific transfer tests. The data from
these tests are presented in Figure 3B and are shown as the mean
lever presses per minute (stimulus minus baseline) when the
stimulus predicted the same outcome as the action (Same) and
when it predicted a different outcome (Different). Baseline levels
of responding during the PIT test in the absence of the stimuli
were not influenced by the various drug treatments and did not
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Figure 2. Effect of D1R and D2R blockade in the NAc shell and core on expression of specific Pavlovian-instrumental transfer. A, All rats received Pavlovian and instrumental training followed by
two consecutive PIT tests. One group performed these two tests under NAc-S infusion of either VEH or a high dose of SCH, while another groupwas infusedwith either vehicle or a high dose of RAC.
Following instrumental retraining, ratswere again submitted to two consecutive PIT tests thatwere identical to the previous ones except that lowdoses of SCH and RACwere infused into theNAc-S.
B, Rats infused with vehicle exhibited specific PIT. Although both doses of SCH impaired specific PIT, only the low dose did so without affecting baseline performance. C, Rats displayed specific PIT
whether theywere infused in theNAc-Swith vehicle or the lowandhigh dose of RAC.D, The performance during the tests revealed that animals exhibited specific PITwhether they had been infused
into the NAc-Cwith VEH, SCH, or RAC. E, Placements of the injection cannula tips in the NAc-S (left) and NAc-C (right) for rats infusedwith SCH (blue) and RAC (red). Distances on the atlas templates
are indicated in millimeters relative to bregma.
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differ (F  1). ANOVA found a main ef-
fect of Drug (F(4,150)  3.8; p  0.001),
Period (F(1,150)  42.7; p  0.001), and a
Drug	 Period interaction (F(4,159) 4.8;
p  0.001). Bilateral infusion of vehicle
(Group VEH-VEH; F(1,44)  21.9; p 
0.001), as well as unilateral infusions of
the D1R antagonist SCH-23390 (Group
VEH-SCH; F(1,26)  13.2; p  0.001) or
the DOR antagonist naltrindole (Group
NAL-VEH; F(1,30)  22.7; p  0.001)
spared outcome-specific transfer. In con-
trast, this transfer was prevented by bilat-
eral infusion of naltrindole (Group NAL-
NAL), or unilateral naltrindole infusion
combined with contralateral infusion of
SCH-23390 (Group NAL-SCH) (both F
values1). The specific impairment pro-
duced by the combination of unilateral
NAL and SCH infusions suggests that
D1Rs and DORs, both essential to gener-
ate PIT, influence a common cellular cir-
cuit in the NAc-S responsible for the
expression of outcome-specific transfer
and, therefore, we next sought to establish
the nature of the circuit mediating this
interaction.
Specific PIT is associated with changes
in the firing patterns of NAc-S CINs
Our previous studies in transgenic mice
and in rats provided strong evidence for
the involvement of DORs expressed in the
NAc-S in specific PIT (Laurent et al., 2012), in particular those
expressed on cholinergic interneurons (Bertran-Gonzalez et al.,
2013). We found in the latter study that contingent Pavlovian
training resulted in an increase of an irregular/burst firing pattern
in CINs immediately after that training, which was accentuated
by administration of the DOR agonist deltorphin. From these
data we hypothesized that the training increased CIN regulation
by DORs, an effect that rendered these neurons more sensitive to
deltorphin treatment. In the present experiment, we aimed to (1)
confirm the specific effect of Pavlovian contingency on firing
responses of NAc-S CINs in rats, and (2) assess whether those
firing changes persisted over further stages of training to be present
at the PIT test.
Two groups of rats, which differed in the manner in which
they were trained during the Pavlovian stage, were submitted to a
PIT test. A contingent group (Group Contingent; n  6) was
trained as before, whereas a noncontingent group (Group Non
Cont; n  7) was exposed to uncorrelated presentations of the
stimuli and outcomes (Fig. 4A). All rats were then given instru-
mental training followed by a single PIT test. The levels of mag-
azine entries across Pavlovian training are presented in Figure 4B.
The statistical analysis found that performance in the presence or
absence of the stimuli depended on the day of training and the
training protocol received (F(7,140) 18.5; p 0.001). Although
noncontingent rats did distinguish between the pre-S and S peri-
ods (F(1,42)  39.0; p  0.001; F(1,111)  5.8; p  0.001), the
stimulus–outcome relationships established were substantially
weaker; noncontingent rats displayed lower levels of magazine
entries in the presence of the stimuli than rats given contingent
training (F(1,77)  8.9; p  0.05), but similar levels of magazine
entry in the absence of the stimuli (F  3.8). Importantly, con-
tingent rats readily discriminated the two periods (F(1,35) 77.4;
p  0.001), and this discrimination grew larger over trials
(F(7,95) 16.3; p 0.001). Following Pavlovian training, all rats
acquired the lever press responses that increased as training pro-
gressed (F(7,103)  88.8; p  0.001). There was no difference
between the two groups of rats (F  0.1; Fig. 4C). We next as-
sessed the effect of noncontingent training on outcome-specific
transfer (Fig. 4D). Performance is plotted as in the previous ex-
periment, since there was no difference in baseline responding
between the two groups (F 0.1). ANOVA revealed no effect of
Group (Cont vs Non Cont; F 0.5) but a main effect of Period
(F(1,25)  7.3; p  0.05) and a Group 	 Period interaction
(F(1,25) 7.5; p 0.05). Thus, contingent rats elevated respond-
ing on the action delivering the outcome predicted by the stimu-
lus that was presented (F(1,25)  6.7; p  0.05), whereas
noncontingent rats distributed their responding on the two avail-
able actions (F 0.1).
Immediately after the test, the brains from rats in Groups
Cont andNonContwere processed for slice electrophysiology. In
NAc-S-containing in vitro slices, using a cell-attached configura-
tion of patch-clamp electrophysiology with least perturbation of
intracellular content, we compared the action potential firing
patterns and spike frequency in identified CINs (Fig. 4E). Com-
pared with noncontingent controls in the presence of synaptic
blockers, we found that the DOR agonist deltorphin (300 nM)
increased the irregular/burst firing pattern of CINs when bath-
applied to the NAc-S preparations of contingently trained rats
(Fig. 4F,G; Mann–WhitneyU test, p 0.05). However, the over-
all action potential frequencies did not differ by deltorphin
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Figure 3. D1Rs and DORs cooperate in the NAc-S to mediate the expression of choice. A, Schematic showing the five distinct
pharmacological treatments involving bilateral infusions in the NAc-S. VEH, gray; NAL, green; SCH, blue. B, The lever press rate
minus baseline revealed that rats bilaterally infused with vehicle (VEH-VEH) or unilaterally infused with either SCH (VEH-SCH) or
NAL (NAL-VEH) displayed specific PIT. In contrast, specific PITwas removed by bilateral infusion of NAL (NAL-NAL) or asymmetrical
infusion of NAL and SCH (NAL-SCH; gray dashed line, baseline). C, Placements of the injection cannula tips in the NAc-S. Distances
on the atlas templates are indicated in millimeters relative to bregma.
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application in both groups (Fig. 4H; Mann–Whitney U test, p 
0.9). These results extend our previous finding in mice that
contingent Pavlovian training specifically influenced CIN firing
(Bertran-Gonzalez et al., 2013), and confirm that the increase in
DOR agonist sensitivity acquired during the initial Pavlovian
phase persists throughout instrumental training and the sub-
sequent PIT test. These data strongly suggest that Pavlovian
conditioning produces cellular changes in NAc-S CINs that
may ultimately contribute to the selective modulation of D1R-
expressing projection neurons that takes place at the moment
of PIT.
The DOR–D1R interaction is mediated by acetylcholine
M4 receptors
Our results so far are consistent with our original findings show-
ing that (1) blockade of DORs in the NAc-S prevents the PIT
effect, and (2) Pavlovian predictive learning triggers DOR trans-
location to the membrane of CINs, an accumulation that is likely
to be necessary to subsequently guide choice between actions
(Laurent et al., 2012; Bertran-Gonzalez et al., 2013). Indeed, our
previous findings showed that the higher the levels of DORs in
the membrane of NAc-S CINs, the larger the PIT effect is. In this
current series, we have highlighted the involvement of D1Rs in
postsynaptic projection neurons in this process, which appear to
be tightly coupled to presynaptic cholinergic events in the NAc-S
to generate PIT. To find the molecular link between postsynaptic
D1R and presynaptic DOR processes in the NAc-S, we explored
the involvement of M4Rs, which are enriched in ventral striatal
areas and are expressed selectively on D1R-expressing MSNs
(Tayebati et al., 2004; Lobo et al., 2006; Guo et al., 2010; Jeon et
al., 2010).
In the next experiment, we tested the effects of M4R blockade
during a PIT test conducted in control conditions or in the pres-
ence of the DOR antagonist naltrindole. To this end, we designed
a pharmacological experiment in rats, which used systemic nal-
trindole to induce a general blockade of DORs with NAc-S infu-
sion of MT3, a highly selective M4R antagonist (Jolkkonen et al.,
1995; Wang et al., 1997; Guo et al., 2010). Rats were bilaterally
implanted with cannulae in the NAc-S (Fig. 5C) and subjected to
the three-stage protocol described previously. They underwent
two transfer tests; one after infusion of vehicle and one after
infusion of MT3, both into the NAc-S, combined with systemic
injection of either vehicle or naltrindole (Fig. 5A), making four
drug treatments; i.e., groups given systemic injection of vehicle
plus bilateral infusion of vehicle (Group VEH-VEH, n  14) or
MT3 (GroupMT3-VEH, n 14) in the NAc-S, and groups given
systemic injection of naltrindole plus bilateral infusion of vehicle
(Group VEH-NAL; n 13) orMT3 (GroupMT3-NAL; n 12).
Rats successfully discriminated between the stimulus and
prestimulus periods across Pavlovian training (F(1,182) 211.2; p
0.001), and this discrimination grew larger across days (F(7,431)
29.2; p  0.001; data not shown). Rats subsequently acquired
lever press responding that increased over the course of instru-
mental training (F(9,269)  93.2; p  0.001; data not shown).
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Figure 4. Contingent Pavlovian training promotes persistent changes in NAc-S CINs that are during PIT. A, Two groups of rats were initially submitted to Pavlovian training. A Noncontingent
group (Non cont; red) received the same number of conditioned stimuli and outcomes (O) as the Contingent group (black), although presentation of stimuli did not predict the delivery of the
outcomes (see Materials and Methods). B–D, Noncontingent training (B) prevented the gradual increase of conditioned responses, otherwise observed in the contingent group. Acquisition of
instrumental performance (C) was equivalent in contingent and noncontingent groups. Levels of lever pressingminus baseline at test (D) revealed that contingent rats exhibited outcome-specific
PIT, whereas noncontingent rats did not. E, A representative cholinergic interneuron of the NAc-S labeled with biocytin during electrophysiological recording. Post hoc immunofluorescence
confirmed the ChAT phenotype of the recorded neuron (left insets). A voltage– current relationship for the labeled neuron in E is also shown (E1 inset). F–H, In the presence of synaptic blockers, the
effect of the DOR agonist deltorphin (300 nM) on spontaneous action potentials in NAc-S CINs from slices of contingently and noncontingently trained rats submitted to PIT. In contingently trained
rats, application of deltorphin increased the basal irregular firing pattern of NAc-S CINs (F, neuron in E) and enhanced the variance of action potential frequency (G), whereas overall action potential
frequency did not differ significantly from Noncontingent rats (H ). Error bars denoteSEM.
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Performance during the PIT tests is
shown in Figure 5B as the mean number
of lever presses per minute (stimulus mi-
nus Baseline) during a stimulus predict-
ing the same outcome as a particular
response (Same) and during a stimulus
predicting a different outcome from a
particular response (Different). The sta-
tistical analysis found no significant effect
of Drug (F  1), but it revealed a main
effect of Period (F(1,98)  31.6; p 
0.001) and Period 	 Group interaction
(F(3,105)  3.1; p  0.05). Indeed, M4R
blockade exerted a different influence
over outcome-specific transfer when that
transfer occurred in the presence or ab-
sence of naltrindole. Animals that only re-
ceived local infusion of MT3 (MT3-VEH;
F(1,26)  18.8; p  0.001) were as able to
display specific PIT as the control animals
(VEH-VEH; F(1,26)  16; p  0.001). As
previously shown (Bertran-Gonzalez et
al., 2013), the PIT response was prevented
by systemic naltrindole treatment (VEH-
NAL; F(1,24)  0.09; p  0.77). Impor-
tantly, local infusion of the M4R
antagonist MT3 blocked the effect of sys-
temic naltrindole on PIT, and the PIT re-
sponse was rescued in MT3 (NAc-S) 
naltrindole (systemic)-treated rats (MT3-
NAL; F(1,22)  6.7; p  0.001). These ef-
fects emerged during the stimuli; no
difference was found among the groups
when the stimuli were absent (F(1,49) 
1.9; p  0.37; data not shown). Overall,
our results have uncovered a mechanism
through which cholinergic modulation of D1R-expressing pro-
jection neurons in the NAc-S is regulated by DORs through the
latter’s expression on CINs to mediate the appropriate choice of
actions during specific Pavlovian-instrumental transfer.
Discussion
The current results provide evidence that D1R-expressing pro-
jection neurons in the NAc-S play a key role in the effect of
predictive learning on choice between goal-directed actions.
Mice given the opportunity to express specific PIT exhibited
high levels of phosphorylated ERK1/2 almost exclusively in
putative D1R-containing MSNs of the NAc-S, demonstrating
strong signaling activity specifically in this subset of NAc-S
projection neurons. Confirming this result, D1R, but not
D2R, blockade in the NAc-S was found to prevent specific PIT
in rats. Moreover, consistent with our previous finding on the
role of DORs during PIT (Laurent et al., 2012) and their plastic
adaptations on CINs during Pavlovian learning (Bertran-
Gonzalez et al., 2013), our current experiments revealed that PIT
was associated with increased sensitivity of CINs to the DOR
agonist deltorphin, confirming the involvement of DORs on
these neurons during choice.
These results clearly imply cooperative activity between D1Rs
and DORs in the NAc-S during PIT and, supporting this, we
found that unilateral NAc-S antagonism of D1Rs combined with
contralateral NAc-S antagonism of DORs prevented specific PIT.
The role of DORs in this process was further confirmed, as both
systemic and local NAc-S blockade of these receptors prevented
PIT expression. In pursuit of the cooperative mechanism be-
tween DOR expression on CINs and dopamine, we considered
the role of the M4Rs in PIT. These receptors are abundant in the
striatum, particularly in the ventral areas (Tayebati et al., 2004).
Moreover, M4Rs are coexpressed with D1Rs selectively in direct
pathway neurons (Lobo et al., 2006), where they exert opposing
influence on cAMP signaling through Gi coupling (Guo et al.,
2010; Jeon et al., 2010). We hypothesized that the increased sen-
sitivity of DORs on CINs and the consequent changes in CIN
firing pattern after Pavlovian conditioning (Bertran-Gonzalez et
al., 2013) produced both a localized reduction in acetylcholine
release and, by reducing inhibition by M4Rs, a decrease in the
cholinergic “clamp” on corticostriatal inputs (Ding et al., 2010)
to generate strong D1R-mediated cellular activity during PIT.
Importantly, in support of this hypothesis, we found that selec-
tive blockade of M4Rs in the NAc-S reduced the inhibitory effect
of naltrindole on PIT and rescued the rats’ capacity to express
appropriate choices during the PIT test.
Although dopamine constitutes amajor source ofmodulation
in the striatum (Gerfen and Surmeier, 2011), other modulators
regulate striatal function in close interplay with dopamine.
For example, cholinergic interneurons (Kawaguchi et al., 1995),
which provide the main source of striatal acetylcholine (Bolam,
1984), ramify very widely to generate among the highest cholin-
ergic activities in the brain (Sorimachi and Kataoka, 1975). An-
other important source of modulation in the striatum comes
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Figure 5. Selective blockade of M4Rs in the NAc-S rescued the deficit in PIT produced by DOR blockade. A, Schematic showing
the four distinct drug treatments administered. NAL (green) and VEH (gray) were given systemically, whereas bilateral NAc-S
infusion involved either the muscarinic toxin 3 (MT3; red) or VEH (gray). B, Rats treated systemically with naltrindole (VEH/NAL)
failed to display specific PIT. However, PIT could be rescued by bilaterally infusing rats with MT3 into the NAc-S (MT3/VEH). Rats
only infused with MT3 (MT3/VEH) exhibited specific PIT similar to control animals (VEH/VEH; gray dashed line, baseline). C,
Placements of the injection cannula tips in the NAc-S. Distances on the atlas templates are indicated in millimeters relative to
bregma.
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from opioidergic systems (Kieffer and Evans, 2009). Prepro-
enkephalin, for example, is a neuropeptide generated exclusively
in striatopallidal projection neurons that, once released as en-
kephalin to the extracellular space, acts on DORs expressed in
different cellular compartments (Steiner and Gerfen, 1998; Le
Merrer et al., 2009). We and others have reported expression of
DORs in the somatic and proximal dendritic membranes of stri-
atal CINs (Le Moine et al., 1994; Scherrer et al., 2006; Bertran-
Gonzalez et al., 2013). Although functional interactions between
some of these neurotransmitters have been reported in the past
(Goldberg et al., 2012; Threlfell et al., 2012), how these systems
cooperate with one another to modulate overall striatal function
and produce relevant behaviors is complex and has remained
elusive. Here, we show that these three neuromodulatory pro-
cesses combine to tightly regulate output neurons in the NAc-S
during PIT. In this context, we recently described the accumula-
tion of DORs in the NAc-S in the somatic membrane of CINs as
a consequence of Pavlovian conditioning (Bertran-Gonzalez et
al., 2013). Given that neitherDORs nor the entireNAc-S region is
necessary for Pavlovian conditioned responding per se (Corbit et
al., 2001; Corbit and Balleine, 2011; Laurent et al., 2012), we
reasoned that these changes of DOR distribution were preparing
ventral CINs for use in guiding instrumental actions during Pav-
lovian cues. Indeed, we found that the extent of DORmembrane
accumulation in NAc-S CINs correlated with performance dur-
ing the PIT test (Bertran-Gonzalez et al., 2013). Here we also
confirmed the functional relevance of this plastic change onCINs
showing that contingent Pavlovian training increased sensitivity
of CIN firing to deltorphin, a direct agonist of DORs, a cellular
adaptation that persisted at least until the moment of PIT.
Based on these results, we propose a functionalmodel describ-
ing the hypothesized cellular interactions occurring in the NAc-S
during PIT, and how the different neuromodulatory systemsmay
cooperate to produce exclusive D1R responses (Fig. 6). In a drug-
free situation, contingent Pavlovian training triggers the accu-
mulation of DORs to the membrane of CINs, rendering these
neurons more sensitive to the enkephalinergic signal even weeks
after Pavlovian training. During PIT (Fig. 6A), intense MSN
stimulation is expected to trigger, among other cellular re-
sponses, the release of enkephalin, which is produced in large
amounts in D2R-MSNs and is the endogenous ligand of DORs
(Steiner and Gerfen, 1998; Le Merrer et al., 2009). This paracrine
signal can exert strong somatic inhibition over DOR-sensitized
CINs, eliciting transient interruptions in their regular firing and a
shift to irregular/burst firing. As shown by several studies, burst-
pause firing responses are expected to generate large acetylcho-
line oscillations in the striatum, which are thought to be central
for corticostriatal plasticity (Schulz and Reynolds, 2013). In this
situation, the sensitive enkephalin influence on CINs can pro-
duce sudden drops of acetylcholine, which would relieve the
inhibitory tone on both corticostriatal synapses and D1R-MSNs—
the latter being mediated throughM4Rs, permitting the expression
of large cAMP-dependent signaling programs in these cells and
the expression ofNAc-S function, leading to congruent stimulus-
driven choices. When naltrindole is present in the NAc-S during
PIT (Fig. 6B), blockade of DORs is expected to antagonize the
effects of endogenously released enkephalin, thus preventing the
local drop in acetylcholine and enabling M4Rs to recover their
inhibitory tone over D1Rs to prevent D1R-mediated cAMP re-
sponses. In contrast, when both naltrindole and the selective
M4R antagonist MT3 are present in the NAc-S in the PIT test
(Fig. 6C), the direct blockade of M4Rs is predicted to suppress
their inhibitory tone over cAMP, allowing D1R-dependent re-
sponses to be expressed independently of the naltrindole-
induced cholinergic state.
Clearly, although this model is speculative and requires fur-
ther experimentation, our evidence to date strongly suggests that
opioids, through their activity at DORs expressed on CINs, pro-
mote stimulus-based choice via cholinergic modulation of D1R-
expressing projection neurons in the NAc-S. Recent work in our
laboratory has established that the projection from the nucleus
accumbens shell to the medial ventral pallidummediates specific
PIT (Leung and Balleine, 2013), and the preferential role for
D1R-expressing striatalMSNs in PIT suggests that this projection
pathway is controlled by D1R-expressing MSNs. Widespread
corticostriatal stimulation in the NAc-S during PIT is, however,
A B C
Figure6. Model of the cooperative interactions betweenopioidergic, acetylcholinergic, anddopaminergic systems in theNAc-S in the expression of choice betweengoal-directed actions in a test
of Pavlovian-instrumental transfer. Each diagram (A–C) exemplifies the molecular interactions occurring in a cortico-direct pathway synapse (D1R-MSN; left) a CIN (center), and a cortico-indirect
pathway synapse (D2R-MSN; right) at the moment of PIT. A corresponds to conditions without pharmacological intervention; B corresponds to a condition in which the selective DOR antagonist
naltrindole (N, red) has been administered in the NAc-S; and C corresponds to a condition in which both naltrindole and the selective M4R blocker MT3 (black) are present in the NAc-S. The green
contour represents the accumulatedDORs in the somatic region of the CIN due to prior Pavlovian conditioning (Bertran-Gonzalez et al., 2013). Blue color represents overactivity. Red color represents
hypoactivity. See Discussion for explanatory details. AC, adenylate cyclase; Ach, acetylcholine; Ca 2, intracellular calcium signal; cAMP, intracellular cAMP signal; DA, dopamine; ENK, enkephalin;
Glut, glutamate; N, naltrindole.
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required to coordinate substantial somatosensory, associative,
and executive information to generate the organized behavioral
pattern congruent with predictive cues on test. Accordingly,
based on recent evidence for simultaneous activity in both D1R-
and D2R-expressing neurons during voluntary movements (Cui
et al., 2013; Isomura et al., 2013), as well as recent models of
coherent corticostriatal oscillations (Koralek et al., 2013), we
should expect both D1R- and D2R-expressing projection neu-
rons to be involved in the oscillatory transmission of this signal,
with upstream cellular events occurring in both MSN popula-
tions. In fact, if strong enough, cortical stimulation can produce
downstream nuclear responses in virtually all striatal neurons,
which could result in the release of neuropeptides, such as sub-
stance P in D1R-MSNs or enkephalin in D2R-MSNs (Sgambato
et al., 1997; Fig. 6). Nevertheless, despite the existence of up-
stream events that are widespread across the two subpopulations,
the dichotomy imposed by the dopaminergic signal through the
distribution of D1Rs and D2Rs, and the opposing cAMP responses
that these receptorspromote, is translated intoexquisitely segregated
downstream molecular responses (Bertran-Gonzalez et al., 2008),
and this segregationof output activity provides interesting clues as
to the overall functional role of the D1R- and D2R-expressing
MSNs in the NAc-S.
Although theNAc-S appears not to be necessary for Pavlovian
or instrumental learning per se (Corbit et al., 2001; Corbit and
Balleine, 2011), local changes induced by Pavlovian and instru-
mental training are necessary to support PIT. Any deficiency in
the integrative processes supporting PIT will, therefore, strongly
affect the stimulus control of action, and deficits in this function
have been associated with a number of disorders, most notably
stimulus-induced relapse in drug seeking after a period of absti-
nence, the stimulus control of food seeking in obesity, and the
loss of control over perseverative actions in a number of psychi-
atric disorders including psychotic disorders and depression
(Hyman, 2005; Seymour and Dolan, 2008; Simpson et al., 2010).
There is, therefore, growing evidence of pathologies in decision-
making involving the NAc-S (Kalivas and Volkow, 2005; Simon
et al., 2011; Stopper and Floresco, 2011) and, given the numerous
pharmacological agents that influence the opioidergic, acetylcho-
linergic, and dopaminergic systems, the current findings may
help in designing potential pharmacological strategies for rescu-
ing those deficits.
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